Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors

NCT06584006 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancy
Lymphocytopenia

Interventions

DRUG: Thymalfasin for injection in combination with Recombinant Human Interleukin-2 Injections
DRUG: Recombinant Human Interleukin-2 Injections

Sponsor

The First Affiliated Hospital of Xiamen University